ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Construction and experimental validation of a B cell-related gene signature to predict the prognosis and immunotherapeutic sensitivity in bladder cancer

Zhou, Ranran; Zhou, Jiawei; Muhuitijiang, Bahaerguli; Zeng, Xiangbo; Tan, Wanlong*南方医科大学
Aging-US2023-6-30
4阅读
引用收藏
分享

摘要

Background: B cells are essential components of tumor microenvironment and exert important functions in anti-tumor immune response. However, the prognosis value of B cell-related genes in bladder cancer (BLCA) remains obscure.Materials and Methods: The infiltrating levels of B cells were measured via the CD20 staining in the local samples and the computational biology analyses in the TCGA-BLCA cohort. The single-cell RNA sequencing analysis, gene-pair strategy, LASSO regression, random forest, and Cox regression were used for B cell-related signature construction. TCGA-BLCA cohort was chosen as the training cohort, and three independent cohorts from GEO and the local cohort were used for external validation. 326 B cells were adopted to explore the association between the model and B cells' biological processes. TIDE algorithm and two BLCA cohorts receiving anti-PD1/PDL1 treatment were utilized to detect its predictive ability to the immunotherapeutic response. Results: High infiltration levels of B cells heralded favorable prognosis, both in the TCGA-BLCA cohort and the local cohort (all P < 0.05). A 5-gene-pair model was established and served as a significant prognosis predictor across multiple cohorts (pooled hazard ratio = 2.79, 95% confidence interval = 2.22-3.49). The model could evaluate the prognosis effectively in 21 of 33 cancer types (P < 0.05). The signature was negatively associated with B cells' activation, proliferation, and infiltrating levels, and could serve as a potential predictor of immunotherapeutic outcomes. Conclusions: A B cell-related gene signature was constructed to predict the prognosis and immunotherapeutic sensitivity in BLCA, helping to guide the personalized treatment.

学科与关键词

关键词
*Equal contributionB cellbladder cancerprognosisimmunotherapytumor immunity
相关
加载中…
  • Construction and experimental validation of a B cell senescence-related gene signature to evaluate prognosis and immunotherapeutic sensitivity in bladder cancer
    Zhou, Ranran; Zhou, Jiawei; Muhuitijiang, Bahaerguli; Tan, Wanlong*FUNCTIONAL & INTEGRATIVE GENOMICS, 2023, 23(1): 3.被引 2
  • Identification of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with bladder cancer
    Yao, Zhihao; Zhang, Henghui; Zhang, Xuejun; Zhang, Zhiyong; Jie, Jirong; Xie, Kunfeng; Li, Fei*; Tan, Wanlong*Frontiers in Genetics, 2022, 13: 923768.被引 1
  • Development and experimental validation of a folate metabolism-related gene signature to predict the prognosis and immunotherapeutic sensitivity in bladder cancer
    Liu, Xincheng; Chen, Chunxiao; Xu, Peng; Chen, Binshen; Xu, Abai; Liu, Chunxiao*FUNCTIONAL & INTEGRATIVE GENOMICS, 2023, 23(4): 291.
查看全部 →

发表信息

论文状态
公开发表
期刊
Aging-US
发表日期
2023-06-30
卷期
第 15 卷, 第 12 期
页码
5355-5380
语言
ENGLISH
成果收录
SCIE
资助标注
Science and Technology Program of Guangzhou [202002030482]; National Natural Science Foundation of China [82073162]

作者

  • Z

    Zhou, Ranran (第一作者)

    southern med univ

  • Z

    Zhou, Jiawei

    southern med univ

查看全部 5 位作者收起作者
  • M

    Muhuitijiang, Bahaerguli

    southern med univ

  • Z

    Zeng, Xiangbo

    southern med univ

  • T

    Tan, Wanlong (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417